Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

API (ASX:API) share price on watch after new govt funding

The API (ASX: API) share price will be on watch today after the company welcome increased government funding.

What is API?

API is the pharmacy company behind Priceline, ClearSkincare, Soul Pattinson Chemist and much more. The Melbourne-based company is more than 100 years old and operates more than 500 chemists and hundreds more are included in its member network.

New government funding

The government is increasing funding for Australia’s network of medicine wholesalers.

API is one of the four members of the National Pharmaceutical Services Association (NPSA) that will benefit from the commitment of additional funding over the next five years, commencing 1 July 2020.

The funding will underpin critical national infrastructure and ensure equality of access to vital medicines for all Australians.

The funding is an additional $92 million and it has introduced a floor price. The NPSA said the investment was necessary to help offset years of funding erosion and ongoing Pharmaceutical Benefits Scheme (PBS) reform and cost increases.

API CEO and managing director Richard Vincent said: “I congratulate everyone involved in the negotiations that led to this outcome. I would particularly like to thank Greg Hunt, the Federal Minister for Health, his advisors and my colleagues at our industry association, the NPSA.”

The API share price before the open was $1.11. This was almost the lowest it has been since 2015. I don’t think API is a fantastic business, but it looks cheap enough (with this extra funding) that it could make a decent return for a contrarian investor. However, I’m not personally going to buy it.

In early trading the API share price is up 2.7%.

[ls_content_block id=”14945″ para=”paragraphs”]

Disclosure: At the time of writing, Jaz doesn’t own shares in any of the businesses mentioned. 

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content